Imunon Stock Soars 17.28% on Nasdaq Compliance

On June 11, 2025, Imunon's stock surged by 17.28% in pre-market trading, marking a significant rise in its share price.

Imunon, Inc. has successfully regained compliance with Nasdaq's Minimum Bid Price Requirement. The company's common stock closed above $1.00 for 10 consecutive trading days, meeting the regulatory standards set by Nasdaq. This achievement is crucial for Imunon as it had previously faced potential delisting due to non-compliance with the minimum bid price and stockholders' equity requirements.

Imunon's efforts to maintain a minimum closing bid price of $1.00 or more have been instrumental in its recent compliance. The company's proactive measures to address regulatory concerns have not only helped it avoid delisting but also boosted investor confidence, contributing to the recent surge in its stock price.